What is the cannabinoid, CBC (also known as cannabichromene), and why should you pay attention? CBC stands apart from THC and CBD with its unique effects on the endocannabinoid system and potential health benefits. This article breaks down the science of CBC, showcasing its anti-inflammatory and neuroprotective properties without the high.
Key Takeaways
- Cannabichromene (CBC) is a non-psychoactive cannabinoid with promising therapeutic potential, including anti-inflammatory, analgesic, and neuroprotective effects, and distinct properties compared to other cannabinoids like THC and CBD.
- CBC interacts uniquely with the endocannabinoid system by modulating enzyme expressions and inhibits the reuptake of anandamide (the bliss molecule) levels, potentially offering advantages in managing pain, inflammation, and other health conditions without direct activation of cannabinoid receptors1
- Current research suggests CBC’s potential health benefits extend to provide anti-inflammatory and analgesic effects, neuroprotection, antitumor properties, mental health management, and daily practical uses through various product forms, maintaining a favorable safety profile with few known side effects.2
Understanding Cannabichromene (CBC)
In 1966, the non-intoxicating cannabinoid CBC was identified by Gaoni and Mechoulam. Its medical promise in areas such as anti-inflammatory, pain-relieving, and brain-protective properties has gained recognition over years of study. Unlike THC, which produces euphoric effects, CBC significantly engages with our body’s own endocannabinoid system to influence endocannabinoid signaling without triggering a high.
CBC is more than just an agonist that binds to cannabinoid receptors. It holds a distinct position within the medicinal cannabis landscape due to its diverse range of health benefits. Ongoing research continues to shed light on its considerable therapeutic potential—capturing the interest of both medical experts and those exploring natural remedies for well-being.
The Chemistry Behind CBC
CBC’s chemical complexity is as fascinating as its potential for medical applications. It possesses a similar structure to CBD and falls within the terpenophenolic class of compounds, with C21H30O2 being its molecular formula. Cannabigerolic acid (CBGA), known as the progenitor cannabinoid, gives rise to CBC.
During the conversion of CBGA into CBC, there are two critical phases involved. Initially, an enzyme by the name of CBCA synthase acts on CBGA causing it to cyclize into cannabichromenic acid (CBCA). Subsequently, either heat or UV light triggers decarboxylation—a natural reaction that transforms CBCA into active CBC. The elaborate chemistry at play not only highlights how remarkable this substance is, but also points toward its promising therapeutic uses.
CBC vs. Other Cannabinoids
CBC, though sharing commonalities with other cannabinoids, possesses unique qualities. Notably, CBC excels over CBD in the area of mitigating inflammatory pain.3 It does not induce psychoactive responses like THC and is considered appealing for formulators seeking to include the compound in ratio cannabinoid products not only for CBC’s unique medicinal advantages, but also for CBC’s ability to amplify the unique properties of the other cannabinoids like THC – D9 and D8 in the formula.
The exploration into CBC has not kept pace with that of CBD and THC, indicating a substantial need for research to comprehend its capabilities fully. The investigation must also address how it measures up to and interacts with different cannabinoids in terms of boosting overall synergistic effects and serving as a formula “amplifier.” Thus, CBC embodies an exciting new avenue in cannabinoid science due to its distinct cannabinoid receptor, affinity and activation properties.
CBC’s Interaction with the Endocannabinoid System
The endocannabinoid system (ECS) is an intricate cellular communication network essential for maintaining the balance of biological functions. CBC engages with this system in several ways, including:
- Notably reducing levels of anandamide in the jejunum after mice have been treated with agents that cause inflammation4
- This reduction occurs through changes to enzyme expression patterns
- It accomplishes this by decreasing GDE1 hyper-expression
- And also by lessening FAAH expression which might affect how much anandamide is available.
CBC’s activity within the ECS has substantial implications. Studies point to its potential role in managing inflammation and suggest it could offer therapeutic benefits for conditions associated with chronic pain and even show promise regarding antitumor effects. CBC seems to impact gastrointestinal motility during inflammatory responses independently from either cannabinoid receptors or TRPA1 receptors, pointing towards additional unidentified pathways involved in its action – a concept prompting curiosity about CBC’s possible roles in mitigating physical stress-related tissue damage.
CBC showcases a novel capacity to influence the ECS without directly engaging cannabinoid receptors, highlighting its singular potential as a therapeutic agent. Such interactions underscore not only the complexity of balancing factors within the ECS but also raise anticipation over what future discoveries about CBC may reveal concerning treatment options for diverse health issues related to bodily regulation systems like those affected during physical stress events leading to tissue harm.
Receptor Affinity and Activation
CBC, a non-psychoactive cannabinoid, does not engage CB1 receptors as its psychoactive counterparts do. Rather, it selectively binds to and activates CB2 receptors with considerable more affinity (256 nM for CB2 vs. 713 nM for CB1). This indicates that CBC operates through a distinctive mechanism compared to other well-known cannabinoids like THC and CBD.
To interact with the endogenous cannabinoid system, CBC also affects vanilloid receptors such as TRPV1, which play roles in how we perceive pain and manage inflammation. The specificity with which CBC stimulates CB2 is evidenced by AM630’s ability to block its effects—confirming that CBC targets this receptor specifically.
The unique way in which CBC engages with these receptors paves new paths for potential therapeutic applications due to its particular receptor interaction profile. It shows promise, particularly because of the distinct pathways it takes when activating the body’s systems compared to other cannabinoids.
Synergistic Effects with Other Cannabinoids
CBC’s medicinal promise extends beyond its sole benefits. This cannabinoid enhances the efficacy of other cannabinoids, including THC and CBD, by engaging in the “entourage effect.” Research indicates that CBC can intensify the actions of these substances within our endocannabinoid system.
In therapy involving both CBC and THC, mental health advantages might be augmented because CBC does not trigger CB1 receptors and thus doesn’t contribute to psychoactive effects. When combined with THC and CBD, CBC may deliver more significant antidepressant outcomes without inducing the intoxication typically linked to just THC.
The potential for collaborative benefits underscores how vital CBC is not merely as an individual treatment option but also as a crucial amplifying ingredient in treatments harnessing multiple cannabinoids.
Clinical Research and Potential Health Benefits
CBC possesses a wide spectrum of possible health advantages that appear quite promising. These include mitigating pain and enhancing mood and providing neuroprotective effects. CBC is recognized for its potent anti-inflammatory capabilities, which may alleviate both swelling and inflammation in the digestive system. It holds potential as an analgesic. Pharmacological studies conducted in vitro using isolated ileum from mice subjected to inflammatory agents have demonstrated CBC’s capacity to curb hypermotility caused by inflammation, highlighting its efficacy in managing both pain and inflammation.5
At the microscopic level, interaction between CBC and CB2 receptors can lead to cellular hyperpolarization, influencing immune response modulation as well as reducing inflammation—a pivotal function considering its applicability across various conditions known for chronic pain and persistent inflammation such as arthritis, multiple sclerosis, and inflammatory bowel disorders. And chronic pain syndromes.
Looking beyond merely controlling pain and thwarting inflammation, CBC’s therapeutic promise might also impact individuals with heart or lung disease—highlighting the need for more research into how it functions under varying pathological scenarios including gut diseases or cancer proliferation issues. Investigative efforts continue to evolve around this substance’s medical uses, potentially opening doors to alternative treatment strategies pertaining to different healthcare challenges.
Anti-inflammatory and Analgesic Effects
As a selective CB2 receptor agonist, CBC directly interacts with the endocannabinoid system and is more effective than THC in hyperpolarizing cells, which may have therapeutic implications. Its anti-inflammatory effects do not involve cannabinoid receptors or TRPA1 channels, but it can inhibit TRPA1 expression in certain conditions. Furthermore, CBC effectively inhibits contractions induced by acetylcholine (ACh) and electrical field stimulation (EFS) in a concentration-dependent manner.
CBC has shown promising results in preclinical studies, including:
The potential of CBC extends beyond its individual actions. It has been found to enhance the anti-inflammatory and antinociceptive responses of other cannabinoids like THC, exhibiting a synergistic effect. These findings underscore the potential of CBC as a promising therapeutic agent for pain and inflammation management, either as a standalone treatment or in combination with other cannabinoids.
Neuroprotective Actions
CBC has shown potential in promoting neurogenesis, the growth of new brain cells, indicating its implications for mental health. It increases the viability of neural stem progenitor cells (NSPCs), which are integral to brain health and can differentiate into astroglial cells for brain maintenance and disease defense.
Apart from specific cellular mechanisms, CBC is being explored for its neuroprotective actions, including the inhibition of nitric oxide production in medical research. These findings highlight the potential of CBC as a neuroprotective agent, offering promising avenues for the treatment of neurological conditions.
Antitumor Properties
The potential of CBC extends into the realm of cancer treatment. It exhibits antitumor effects in breast cancer models, demonstrating its potential as a therapeutic agent against cancer. CBC fights cancer by interacting with anandamide in the body and inhibiting its uptake, which leads to the inhibition of the growth of new cancer cells.6
These findings suggest that red blood cell count, which carries oxygen, and bone marrow could play a crucial role in cancer therapy, offering a natural, non-toxic alternative to traditional cancer treatments. By analyzing a blood sample, researchers can further understand the mechanisms involved in bone marrow failure, low platelet count, and white blood cell count, and validate these findings in clinical studies involving red blood cell count, bone marrow disease and the overall presence of red blood cells.7
CBC for Mental Health
The global issue of mental health is gaining more attention, and the emerging importance of CBC for treating mental health conditions has become clear. Research on animal models indicates that certain cannabinoids, including CBC, may exert antidepressant effects. In particular, investigations into rodent behavior have revealed that CBC could lift mood through its antidepressant-like qualities.8
As a relatively minor but powerful cannabinoid, there’s an increasing recognition of CBC’s potential in acting as a safe antidepressant without serious negative side effects. These developments present new opportunities to employ CBC in addressing mental health issues and offer a promising substitute to conventional psychotropic drugs.
Mood Enhancement Without Psychoactivity
The capacity of CBC to improve mood without the psychoactive impacts frequently linked with cannabis consumption is particularly encouraging. Demonstrating antidepressant-like qualities, CBC has been shown to lessen the period mice remain immobile in behavior assessments while avoiding THC’s mind-altering effects.
CBC does not affect regular movement, but effectively restores behaviors that are disrupted by inflammation. This suggests it can bolster mood without inducing psychoactive consequences. For those dealing with anxiety and who might be more sensitive to THC’s effects, this means they could gain from cannabinoids’ therapeutic advantages minus the stress-provoking high.
Such research highlights CBC as an optimistic alternative for enhancing mood and addressing mental health issues, potentially influencing red blood cell volume in its mechanism of action.
Practical Uses of CBC in Everyday Life
The therapeutic promise of CBC is matched by its considerable relevance to daily well-being. This cannabinoid interacts with multiple key bodily sites, enhancing its suitability for regular health regimens. Individuals can adopt CBC into their personal care practices through products aimed at critical areas such as:
CBC’s adaptability lends itself to a range of everyday uses, spanning from nutritional add-ons to cosmetic applications. With ongoing research shedding light on CBC’s advantages, we anticipate a broader scope for seamlessly integrating this compound into day-to-day living, thereby promoting an all-encompassing approach to maintaining health.
CBC Oil and Tinctures
Incorporating CBC into consumer goods products and formulas for day-to-day consumption is frequently done by using CBC in gummies, vapes, oils and tinctures as stand-alone CBC products and as part of a ratio product in concert with other cannabinoids.
The response to CBC isolate oil varies from person to person and unfolds over time with regular usage. As with the exploration of any new dietary supplement, consumers should start with small amounts and gradually increase the dose to address specific need states while ensuring that they seek advice from a healthcare provider on its proper use.
Topical Applications and Skin Care
Applying CBC directly to the skin as a topical treatment, such as creams or balms, may also provide localized benefits and is effective in managing skin health. It has been demonstrated that CBC can:
- Decrease inflammation which helps prevent acne
- Inhibit overproduction of lipids by sebaceous glands
- Cut down on arachidonic acid levels necessary for lipid creation
These topical applications of CBC are designed specifically for targeted relief and prove particularly useful following strenuous activities.
Enriched with additional analgesics and soothing agents, some formulations of CBC topicals offer enhanced effectiveness for recovery and focused support. With ongoing research into its potential advantages, we can anticipate a broader access to these kinds of products allowing people to exploit the therapeutic properties offered by this potent cannabinoid via an external application method.
Safety Profile and Market Availability
Consumer interest in CBC infused products is on the rise, and it’s crucial to comprehend its safety characteristics and its accessibility within the marketplace. It’s encouraging to note that CBC:
- isn’t listed under the Convention on Psychotropic Substances which indicates that it doesn’t produce psychoactive effects
- shows promise for therapeutic use
- has garnered growing attention as well as investment towards research and developing CBC-centric products
As ongoing studies continue delving into possible dangers and adverse reactions associated with CBC, preliminary results indicate a positive safety profile—particularly when juxtaposed with numerous traditional medical interventions. With an upsurge of accessible CBC-infused products entering consumer markets, there lies a broad horizon for both medicinal uses and day-to-day health applications available globally.
Risks and Side Effects
Evaluating the possible hazards and adverse reactions of CBC is crucial, as with any substance. Instances of side effects reported from taking CBC consist of experiencing a dry mouth sensation and feelings of lightheadedness. Even though these symptoms are usually short-lived and not severe, individuals contemplating the use of any new supplement like CBC should seek advice from medical experts.
When it comes to safety profiles, CBC appears advantageous, especially as compared to numerous standard treatment options available. Notably non-intoxicating in nature, its associated side effects tend to be minor and ephemeral, which positions it as an attractive option for medicinal purposes. It remains critical that anyone initiating usage begin with conservative dosages before incrementally augmenting them if necessary – always proceeding under professional medical supervision.
Finding Quality CBC for Your New Product Development
As the market for CBC products rapidly expands, it’s becoming more straightforward to locate high quality, trustworthy CBD manufacturers and CBC distributors. In response to consumer demand, an increasing variety of high potency CBC products have launched. As you plan your next CBC infused product, it’s important to identify a stable CBC supplier that offers reliable, batch-to-batch consistency in color and potency as well as third-party laboratory tests as a means to verify the purity and quality of their products.
Click here for to explore our CBC products.
Summary
This exploration of CBC reveals its unique therapeutic potential and practical applications. From its distinctive interactions with the endocannabinoid system to its synergistic and amplifying effects with other cannabinoids, CBC is a potent player in the cannabis pharmacopeia. Its anti-inflammatory, neuroprotective, and antitumor properties, combined with its potential for mental health and everyday use, make CBC a promising candidate for further research and therapeutic use.
While the safety profile of CBC appears favorable, and its market availability is increasing, it’s important to have a strong supplier relationship with a reputable CBC distributor. As research continues to uncover the full potential of CBC, its role in health and wellness is poised to grow, offering exciting possibilities for those seeking natural alternatives for health management through CBC infused products like CBC vapes, CBC gummies, and CBC tinctures.
Frequently Asked Questions
Q: What is cannabichromene (CBC) and how does it differ from other cannabinoids?
A: Discovered in 1966, Cannabichromene (CBC) stands out among cannabinoids for its absence of psychoactive properties and for being more effective than CBD at relieving inflammatory pain. Despite sharing similarities with other cannabinoids, it is distinguished by these unique characteristics.
Q: How does CBC interact with the endocannabinoid system?
A: CBC exerts a complex and multifaceted influence on the endocannabinoid system through its distinctive interaction with various components: it influences enzyme expressions, engages CB2 receptors as well as TRPV1 and TRPA1 receptors, and notably reduces anandamide levels in the inflamed jejunum of mice. This showcases CBC’s comprehensive impact within this biological system.
Q: What are the potential health benefits of CBC?
A: CBC, with its capacity to alleviate pain, elevate mood, protect the nervous system, reduce inflammation and encourage the growth of new brain cells, holds promise as a compound that can significantly contribute to overall health and wellness.
Q: How can CBC be incorporated into a consumer’s everyday life?
A: Incorporating CBC into your everyday life can be achieved with minimal effort by utilizing a CBC vape, consuming a CBC-infused gummy, or a CBC tincture, mixing it into meals or beverages, or applying it directly to the skin for localized relief and skincare benefits. These techniques offer straightforward and practical ways to make CBC a regular part of your daily regimen.
More Questions About CBC?
Don’t hesitate to reach out with any questions or concerns about anything that we didn’t cover in this article. Our hemp experts are ready to help. Call 1.800.685.8084 or email us at sales@mcnutraceuticals.com.
Citations:
- https://doi.org/10.1111/j.1476-5381.2012.01879.x [↩]
- Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Cannabinoids: Therapeutic Use in Clinical Practice. Int J Mol Sci. 2022 Mar 19;23(6):3344. doi: 10.3390/ijms23063344. PMID: 35328765; PMCID: PMC8952215. [↩]
- Gojani EG, Wang B, Li DP, Kovalchuk O, Kovalchuk I. Anti-Inflammatory Effects of Minor Cannabinoids CBC, THCV, and CBN in Human Macrophages. Molecules. 2023 Sep 7;28(18):6487. doi: 10.3390/molecules28186487. PMID: 37764262; PMCID: PMC10534668. [↩]
- Izzo AA, Capasso R, Aviello G, Borrelli F, Romano B, Piscitelli F, Gallo L, Capasso F, Orlando P, Di Marzo V.Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol. 2012 Jun;166(4):1444-60. Doi: 10.1111/j.1476-5381.2012.01879.x. PMID: 22300105; PMCID: PMC3417459. [↩]
- Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Front Pharmacol. 2021 Nov 29;12:777804. doi: 10.3389/fphar.2021.777804. PMID: 34916950; PMCID: PMC8669157. [↩]
- Tomko AM, Whynot EG, Ellis LD, Dupré DJ. Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers (Basel). 2020 Jul 21;12(7):1985. doi: 10.3390/cancers12071985. PMID: 32708138; PMCID: PMC7409346. [↩]
- Voicu V, Brehar FM, Toader C, Covache-Busuioc RA, Corlatescu AD, Bordeianu A, Costin HP, Bratu BG, Glavan LA, Ciurea AV. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. Biomolecules. 2023 Sep 14;13(9):1388. doi: 10.3390/biom13091388. PMID: 37759788; PMCID: PMC10526757. [↩]
- Study: https://doi.org/10.1016/j.pbb.2010.03.004 [↩]
